3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1
1
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
3
Conditions
Small Cell Lung Carcinoma
3
Neuroendocrine Tumors
1
Neoplasms
1
Extensive Stage Small Cell Lung Cancer
1
Interventions
Etoposide
30
Carboplatin
29
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
Specimen Handling
9
PM 01183
9
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
olaparib
5
berzosertib
4
anlotinib
4
Radiotherapy
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Paclitaxel
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
cabozantinib
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
AMG 757
×
90 days
×
Clear all
NCT07005128
2026-06-04
DeLLphi-312
Amgen
Phase 3
Recruiting
330 enrolled
NCT06598306
2026-05-29
DeLLphi-308
Amgen
Phase 1
Recruiting
220 enrolled
NCT06117774
2026-04-29
DeLLphi-306
Amgen
Phase 3
Active not recruiting
404 enrolled